Emergent BioSolutions Inc. (EBS)

NYSE Currently up 5.66 (+210.41%) in today's trading session

Track congressional stock trades in Emergent BioSolutions Inc. (EBS). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Emergent BioSolutions Inc. is currently trading at $8.35, positioned at 43% of its 52-week range ($4.02 – $14.06). View which politicians have recently bought or sold EBS and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$8.35
24h Change
+5.66 (+210.41%)
52 Week Range
$4.02$14.06
View on NASDAQ

Emergent BioSolutions Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for EBS

Select to highlight on chart
3 transactions
Compliance: 100%
Josh Gottheimer05 Nov 202113 Dec 2021SaleStock$1,001 - $15,000N/A (Sale Transaction)
Josh Gottheimer18 Oct 202115 Nov 2021PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)
Josh Gottheimer15 Sept 202113 Oct 2021SaleStock$1,001 - $15,000N/A (Sale Transaction)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$438.54M

Volume

1.18M

Beta

2.44

P/E Ratio

8.98

Fundamentals

EPS

$0.93

Div. Yield

Open

$8.18

Day Range

$7.97 — $8.44

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE · USD
Country
US
CEO
Joseph C. Papa Jr.
IPO Date
2006-11-15

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's product...

Earnings

Next Report

Q1 2026

13 May

EPS Est.

$-0.25

Rev. Est.

$205M

Days Until

64

Recent Quarters

Q4 202526 Feb
EPS$-0.43
Miss 490.9%
Q3 202529 Oct
EPS$1.06
Beat 983.3%
Q2 20256 Aug
EPS$0.16
Beat 161.5%
Q1 20257 May
EPS$0.71
Beat 44.9%
Q4 20243 Mar
EPS$0.05
Beat 114.3%
Q3 20246 Nov
EPS$1.37
Beat 179.6%
Q2 20246 Aug
EPS$-2.32
Miss 139.2%
Q1 20241 May
EPS$0.59
Beat 168.6%
Q4 20236 Mar
EPS$-0.77
Miss 133.3%
Q3 202311 Dec
EPS$-1.76
Q3 202311 Dec
EPS$-1.44
Miss 1100.0%
Q2 20238 Aug
EPS$-1.06
Miss 8.2%
Q2 20238 Aug
EPS$-5.15
Q1 20239 May
EPS$-3.17
Miss 89.8%
Q4 202227 Feb
EPS$-1.76
Q3 20228 Nov
EPS$-1.27
Miss 2016.7%
Q2 20221 Aug
EPS$-0.86
Miss 236.5%
Q1 202228 Apr
EPS$0.18
Miss 25.0%
Q1 202228 Apr
EPS$-0.07
Q4 202124 Feb
EPS$4.50
Beat 5.4%
Q3 20214 Nov
EPS$-0.36
Miss 117.7%
Q3 20214 Nov
EPS$-0.65
Q2 202129 Jul
EPS$0.33
Miss 81.8%
Q1 202129 Apr
EPS$1.53
Beat 36.6%
Q4 202018 Feb
EPS$3.67
Beat 15.1%
Q3 20205 Nov
EPS$2.19
Beat 6.8%
Q2 202030 Jul
EPS$1.98
Beat 191.2%
Q1 202030 Apr
EPS$0.01
Beat 150.0%
Q4 201920 Feb
EPS$1.57
Miss 6.0%
Q3 20196 Nov
EPS$1.21
Beat 92.1%
Q2 20191 Aug
EPS$0.12
Miss 25.0%
Q1 20192 May
EPS$-0.13
Miss 200.0%
Q4 201821 Feb
EPS$0.75
Beat 22.9%
Q3 20181 Nov
EPS$0.55
Miss 11.3%
Q2 20182 Aug
EPS$1.07
Beat 21.6%
Q1 20183 May
EPS$-0.03
Miss 110.0%
Q4 201722 Feb
EPS$0.74
Beat 5.7%
Q3 20172 Nov
EPS$0.73
Beat 78.0%
Q2 20173 Aug
EPS$0.13
Miss 50.0%
Q1 20174 May
EPS$0.29
Miss 3.3%
Q4 201623 Feb
EPS$0.74
Beat 54.2%
Q3 20167 Nov
EPS$0.58
Beat 123.1%
Q2 20164 Aug
EPS$-0.18
Beat 21.7%
Q1 20165 May
EPS$0.16
Beat 260.0%
Q4 201525 Feb
EPS$0.78
Beat 11.4%
Q3 20155 Nov
EPS$0.83
Beat 50.9%
Q2 20156 Aug
EPS$0.36
Beat 100.0%
Q1 20157 May
EPS$-0.50
Miss 8.7%
Q4 20145 Mar
EPS$0.75
Beat 8.7%
Q4 201423 Jan
EPS$0.47
Q2 20147 Aug
EPS$0.24
Miss 7.7%
Q1 20148 May
EPS$-0.40
Miss 185.7%
Q4 20136 Mar
EPS$0.41
Beat 13.9%
Q3 20137 Nov
EPS$0.36
Beat 71.4%
Q2 20135 Aug
EPS$0.29
Beat 38.1%
Q1 20132 May
EPS$-0.22
Miss 144.4%
Q4 20127 Mar
EPS$0.44
Miss 2.2%
Q3 20121 Nov
EPS$0.18
Beat 28.6%
Q2 20122 Aug
EPS$0.21
Miss 8.7%
Q1 20123 May
EPS$-0.02
Beat 86.7%
Q4 20118 Mar
EPS$0.78
Beat 8.3%
Q3 20113 Nov
EPS$0.04
Miss 60.0%
Q2 20114 Aug
EPS$0.39
Beat 14.7%
Q1 20115 May
EPS$-0.61
Miss 17.3%
Q4 201010 Mar
EPS$0.76
Beat 13.4%
Q3 20104 Nov
EPS$0.41
Miss 21.1%
Q2 20105 Aug
EPS$0.31
Beat 19.2%
Q1 20105 May
EPS$0.08
Miss 52.9%
Q4 20094 Mar
EPS$0.13
Beat 160.0%
Q3 20095 Nov
EPS$0.03
Miss 50.0%
Q2 20096 Aug
EPS$0.48
Beat 60.0%
Q1 20097 May
EPS$0.35
Beat 169.2%
Q4 20085 Mar
EPS$0.05
Beat 150.0%
Q3 20086 Nov
EPS$0.34
Beat 88.9%
Q2 20087 Aug
EPS$0.06
Miss 73.9%
Q1 20087 May
EPS$0.24
Miss 11.1%
Q4 20077 Mar
EPS$0.93
Beat 6.9%
Q3 20072 Nov
EPS$0.10
Beat 475.0%
Q2 20076 Aug
EPS$-0.17
Beat 32.0%
Q1 20079 May
EPS$-0.10
Miss 599.8%
Q4 200622 Mar
EPS$1.03
Beat 30.4%
Q2 200630 Sept
EPS$-0.05
Q1 200630 Jun
EPS$-0.05
Q4 200531 Mar
EPS$-0.05
Q3 200531 Dec
EPS$0.38
Q2 200530 Sept
EPS$0.09
Q1 200530 Jun
EPS$0.09
Q4 200431 Mar
EPS$0.09
Q3 200431 Dec
EPS$0.14
Q2 200430 Sept
EPS$0.14
Q1 200430 Jun
EPS$0.14
Q4 200331 Mar
EPS$0.14
Q3 200031 Dec
EPS$-1.74

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.